Aethlon Medical, Inc. (AEMD)
USD 0.33
(-5.27%)
USD 0.33
(-5.27%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | - USD | -100.0% |
| 2023 | 574.24 Thousand USD | 95.21% |
| 2022 | 294.16 Thousand USD | -55.37% |
| 2021 | 659.1 Thousand USD | 1.37% |
| 2020 | 650.18 Thousand USD | 183.15% |
| 2019 | 229.62 Thousand USD | 53.47% |
| 2018 | 149.62 Thousand USD | -61.84% |
| 2017 | 392.07 Thousand USD | -55.78% |
| 2016 | 886.57 Thousand USD | 16.28% |
| 2015 | 762.41 Thousand USD | -53.05% |
| 2014 | 1.62 Million USD | 32.01% |
| 2013 | 1.23 Million USD | -9.53% |
| 2012 | 1.35 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | -100.0% |
| 2024 Q4 | - USD | 0.0% |
| 2024 FY | - USD | -100.0% |
| 2024 Q3 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 FY | 574.24 Thousand USD | 95.21% |
| 2023 Q4 | 574.24 Thousand USD | 0.0% |
| 2022 FY | 294.16 Thousand USD | -55.37% |
| 2022 Q1 | 131.96 Thousand USD | 285.49% |
| 2022 Q2 | 131.96 Thousand USD | 0.0% |
| 2022 Q4 | 13.11 Thousand USD | -23.37% |
| 2022 Q3 | 17.11 Thousand USD | -87.03% |
| 2021 FY | 659.1 Thousand USD | 1.37% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q4 | 34.23 Thousand USD | -94.52% |
| 2021 Q3 | 624.87 Thousand USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q4 | 206.72 Thousand USD | -50.0% |
| 2020 Q1 | 30 Thousand USD | -62.5% |
| 2020 FY | 650.18 Thousand USD | 183.15% |
| 2020 Q2 | - USD | -100.0% |
| 2020 Q3 | 413.45 Thousand USD | 0.0% |
| 2019 Q1 | 149.62 Thousand USD | 100.0% |
| 2019 Q2 | - USD | -100.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q4 | 80 Thousand USD | 0.0% |
| 2019 FY | 229.62 Thousand USD | 53.47% |
| 2018 FY | 149.62 Thousand USD | -61.84% |
| 2018 Q3 | 74.81 Thousand USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | 74.81 Thousand USD | -0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | 392.07 Thousand USD | -55.78% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q2 | 387.43 Thousand USD | 8258.96% |
| 2017 Q1 | 4635.00 USD | -97.74% |
| 2016 FY | 886.57 Thousand USD | 16.28% |
| 2016 Q3 | 301.03 Thousand USD | 59.81% |
| 2016 Q2 | 188.36 Thousand USD | -2.15% |
| 2016 Q4 | 204.66 Thousand USD | -32.01% |
| 2016 Q1 | 192.5 Thousand USD | -3.07% |
| 2015 Q4 | 198.61 Thousand USD | 494.04% |
| 2015 FY | 762.41 Thousand USD | -53.05% |
| 2015 Q1 | 51.29 Thousand USD | -92.74% |
| 2015 Q2 | 479.07 Thousand USD | 833.94% |
| 2015 Q3 | 33.43 Thousand USD | -93.02% |
| 2014 Q1 | 195.59 Thousand USD | -51.63% |
| 2014 Q2 | 644.88 Thousand USD | 229.7% |
| 2014 Q3 | 76.31 Thousand USD | -88.17% |
| 2014 Q4 | 706.97 Thousand USD | 826.41% |
| 2014 FY | 1.62 Million USD | 32.01% |
| 2013 Q4 | 404.36 Thousand USD | 93.68% |
| 2013 FY | 1.23 Million USD | -9.53% |
| 2013 Q1 | 216.74 Thousand USD | -46.02% |
| 2013 Q2 | 400.11 Thousand USD | 84.6% |
| 2013 Q3 | 208.78 Thousand USD | -47.82% |
| 2012 FY | 1.35 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 100.0% |
| 2012 Q3 | 958.07 Thousand USD | 0.0% |
| 2012 Q4 | 401.54 Thousand USD | -58.09% |
| 2011 Q4 | -23.6 Million USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 100.0% |
| BrainsWay Ltd. | 31.78 Million USD | 100.0% |
| Cerus Corporation | 156.36 Million USD | 100.0% |
| Envoy Medical, Inc. | 316 Thousand USD | 100.0% |
| electroCore, Inc. | 16.03 Million USD | 100.0% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | 100.0% |
| IceCure Medical Ltd | 3.22 Million USD | 100.0% |
| Inogen, Inc. | 315.66 Million USD | 100.0% |
| OrthoPediatrics Corp. | 148.73 Million USD | 100.0% |
| Lucid Diagnostics Inc. | 2.42 Million USD | 100.0% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | 100.0% |
| MaxCyte, Inc. | 41.28 Million USD | 100.0% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | 100.0% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | 100.0% |
| Orthofix Medical Inc. | 746.64 Million USD | 100.0% |
| PAVmed Inc | 2.45 Million USD | 100.0% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 100.0% |
| RxSight, Inc. | 89.07 Million USD | 100.0% |
| Sight Sciences, Inc. | 81.05 Million USD | 100.0% |
| SI-BONE, Inc. | 138.88 Million USD | 100.0% |
| TELA Bio, Inc. | 58.45 Million USD | 100.0% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 100.0% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 100.0% |
| Acutus Medical, Inc. | 7.16 Million USD | 100.0% |
| Talis Biomedical Corporation | 412 Thousand USD | 100.0% |
| Spectral AI, Inc. | 18.05 Million USD | 100.0% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 100.0% |
| CVRx, Inc. | 39.29 Million USD | 100.0% |
| DIH Holding US, Inc. Warrants | - USD | NaN% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | 100.0% |
| Bioventus Inc. | 512.34 Million USD | 100.0% |
| Venus Concept Inc. | 76.35 Million USD | 100.0% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 100.0% |
| LivaNova PLC | 1.15 Billion USD | 100.0% |
| 908 Devices Inc. | 50.22 Million USD | 100.0% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 100.0% |
| Nemaura Medical Inc. | 77.04 Thousand USD | 100.0% |
| NeuroPace, Inc. | 65.42 Million USD | 100.0% |
| LENSAR, Inc. | 42.16 Million USD | 100.0% |
| Apyx Medical Corporation | 52.34 Million USD | 100.0% |
| Cutera, Inc. | 212.36 Million USD | 100.0% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 100.0% |
| BioSig Technologies, Inc. | 18 Thousand USD | 100.0% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 100.0% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 100.0% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 100.0% |
| Axonics, Inc. | 366.37 Million USD | 100.0% |
| Outset Medical, Inc. | 130.37 Million USD | 100.0% |
| IRIDEX Corporation | 51.86 Million USD | 100.0% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 100.0% |
| IRadimed Corporation | 65.56 Million USD | 100.0% |
| Tivic Health Systems, Inc. | 1.17 Million USD | 100.0% |
| INVO Bioscience, Inc. | 3.02 Million USD | 100.0% |
| Telesis Bio, Inc. | 27.5 Million USD | 100.0% |
| Viemed Healthcare, Inc. | 183 Million USD | 100.0% |
| Varex Imaging Corporation | 811 Million USD | 100.0% |
| Quipt Home Medical Corp. | 221.74 Million USD | 100.0% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | NaN% |
| Pulmonx Corporation | 68.67 Million USD | 100.0% |
| Dynatronics Corporation | 32.53 Million USD | 100.0% |
| Modular Medical, Inc. | - USD | NaN% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 100.0% |
| Semler Scientific, Inc. | 68.18 Million USD | 100.0% |
| InMode Ltd. | 492.04 Million USD | 100.0% |
| Bruker Corporation | 2.96 Billion USD | 100.0% |
| Cytosorbents Corporation | 36.34 Million USD | 100.0% |
| DexCom, Inc. | 3.62 Billion USD | 100.0% |
| Align Technology, Inc. | 3.86 Billion USD | 100.0% |
| Viveve Medical, Inc. | 6.42 Million USD | 100.0% |
| ZimVie Inc. | 457.43 Million USD | 100.0% |
| Movano Inc. | - USD | NaN% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 100.0% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | 100.0% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | NaN% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 100.0% |
| Profound Medical Corp. | 7.33 Million USD | 100.0% |
| Insulet Corporation | 1.69 Billion USD | 100.0% |
| enVVeno Medical Corporation | - USD | NaN% |
| Surmodics, Inc. | 126.07 Million USD | 100.0% |
| iCAD, Inc. | 17.31 Million USD | 100.0% |
| Nuwellis, Inc. | 8.86 Million USD | 100.0% |
| Biotricity, Inc. | 12.06 Million USD | 100.0% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 100.0% |
| InspireMD, Inc. | 6.2 Million USD | 100.0% |
| PAVmed Inc. | 2.45 Million USD | 100.0% |
| BIOLASE, Inc. | 49.16 Million USD | 100.0% |
| Beyond Air, Inc. | 1.15 Million USD | 100.0% |
| FONAR Corporation | 102.88 Million USD | 100.0% |
| AxoGen, Inc. | 159.01 Million USD | 100.0% |
| Vivani Medical, Inc. | - USD | NaN% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 100.0% |
| Inari Medical, Inc. | 493.63 Million USD | 100.0% |
| UFP Technologies, Inc. | 400.07 Million USD | 100.0% |
| QT Imaging Holdings, Inc. | - USD | NaN% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | 100.0% |
| Tenon Medical, Inc. | 2.92 Million USD | 100.0% |
| Autonomix Medical, Inc. Common Stock | - USD | NaN% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 100.0% |
| AdaptHealth Corp. | 3.2 Billion USD | 100.0% |
| Sintx Technologies, Inc. | 2.62 Million USD | 100.0% |
| NanoVibronix, Inc. | 2.28 Million USD | 100.0% |
| Quanterix Corporation | 122.36 Million USD | 100.0% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | NaN% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 100.0% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 100.0% |
| TransMedics Group, Inc. | 241.62 Million USD | 100.0% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 100.0% |
| NeuroMetrix, Inc. | 5.9 Million USD | 100.0% |
| Hyperfine, Inc. | 11.03 Million USD | 100.0% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 100.0% |
| Biomerica, Inc. | 5.41 Million USD | 100.0% |
| Bone Biologics Corporation | - USD | NaN% |
| AVITA Medical, Inc. | 50.56 Million USD | 100.0% |
| Bluejay Diagnostics, Inc. | - USD | NaN% |
| Silk Road Medical, Inc | 177.13 Million USD | 100.0% |